Safety and Efficacy of the Propel Mini and Propel Nova Steroid-Eluting Sinus Implant in Frontal Sinus
Public ClinicalTrials.gov record NCT02266810. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
The PROGRESS Study: Safety and Efficacy of the Propel Mini and Propel Nova Steroid-Eluting Sinus Implants Following Surgical Opening of the Frontal Sinus for Chronic Sinusitis: A Randomized Blinded Controlled Study
Study identification
- NCT ID
- NCT02266810
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Intersect ENT
- Industry
- Enrollment
- 160 participants
Conditions and interventions
Conditions
Interventions
- PROPEL Mini Sinus Implant. Device
- Sinus Surgery alone Procedure
- Propel Nova Sinus Implant Device
Device · Procedure
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2014
- Primary completion
- Mar 31, 2016
- Completion
- Sep 30, 2016
- Last update posted
- Aug 14, 2018
2014 – 2016
United States locations
- U.S. sites
- 10
- U.S. states
- 9
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Sacramento Ear, Nose and Throat | Sacramento | California | 95815 | — |
| Breathe Clear Institute of Sinus and Allergy Relief | Torrance | California | 90503 | — |
| The Connecticut Center for Advanced ENT Care | Norwalk | Connecticut | 06851 | — |
| George Washington University Medical Faculty Associates | Washington D.C. | District of Columbia | 20006 | — |
| ENT of Georgia | Atlanta | Georgia | 30342 | — |
| Advanced ENT and Allergy | Louisville | Kentucky | 40207 | — |
| Albany ENT and Allergy | Albany | New York | 12206 | — |
| Oregon Health and Science University | Portland | Oregon | 97239 | — |
| University of Texas Health Science Center at Houston | Houston | Texas | 77030 | — |
| East Virginia Medical School | Norfolk | Virginia | 23507 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02266810, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 14, 2018 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02266810 live on ClinicalTrials.gov.